Cargando…
Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients
Immune checkpoints are powerful inhibitory molecules that promote tumor survival. Their blockade is now recognized as providing effective therapeutic benefit against cancer. Human leukocyte antigen G (HLA‐G), a recently identified immune checkpoint, has been detected in many types of primary tumors...
Autores principales: | Tronik‐Le Roux, Diana, Renard, Julie, Vérine, Jérôme, Renault, Victor, Tubacher, Emmanuel, LeMaoult, Joel, Rouas‐Freiss, Nathalie, Deleuze, Jean‐François, Desgrandschamps, François, Carosella, Edgardo D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664004/ https://www.ncbi.nlm.nih.gov/pubmed/28815885 http://dx.doi.org/10.1002/1878-0261.12119 |
Ejemplares similares
-
The Dual Role of HLA-G in Cancer
por: Rouas-Freiss, Nathalie, et al.
Publicado: (2014) -
Human Keratinocytes Inhibit CD4(+) T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints
por: Mestrallet, Guillaume, et al.
Publicado: (2021) -
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
por: García, Marcela, et al.
Publicado: (2020) -
Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status
por: Mestrallet, Guillaume, et al.
Publicado: (2022) -
Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G
por: Mestrallet, Guillaume, et al.
Publicado: (2021)